Widespread involvement of purpura related to gastrointestinal involvements in adults with immunoglobulin A vasculitis

Immunoglobulin A vasculitis (IgAV) is a type of vasculitis affecting small vessels with deposition of immune complexes consisting of IgA and complement component 3. IgAV involves the skin, gastrointestinal (GI) tract, joints, and kidneys. Adult patients have higher risks of gastrointestinal tract involvement than children. To investigate the risk factors of the GI tract involvements in adult IgAV patients, we enrolled 29 adult (aged ≥ 20 years) Japanese patients recently (from 2013 to 2019) histopathologically diagnosed with IgAV and classified them into the GI lesion (+) group and the GI lesion (−) group. All patients presented with purpura on the lower extremities; moreover, GI lesion (+) patients presented significantly more with extensive purpura on the upper extremities, and low levels of factor XIII activity (≤70%) than gastrointestinal lesion (−) patients (87.5% vs 28.6% [P = .004]; odds ratio [OR], 17.5; 95% confidence interval [CI], 2.4 to 366], and 57.1% vs 14.3% [P = .04]; OR, 8; 95% CI, 1.06 to 83.9, respectively). There was no significant difference between the two groups in the populations with extensive purpura on the trunk, arthralgia, hematuria, proteinuria, or elevated serum levels of C‐reactive protein or IgA. Widespread purpura on the upper extremities accompanied by a low factor XIII activity is a suggestive factor for severe GI lesions in adult IgAV patients.

[1]  A. Mohn,et al.  Factor XIII as a potential predictor of severe gastrointestinal involvement in Henoch Schoenlein purpura: A case study research , 2020, Journal of paediatrics and child health.

[2]  E. Thervet,et al.  Gastrointestinal involvement in adult IgA vasculitis (Henoch-Schönlein purpura): updated picture from a French multicentre and retrospective series of 260 cases. , 2020, Rheumatology.

[3]  Xiaohui Cui,et al.  Henoch-Schönlein purpura with intussusception and hematochezia in an adult , 2019, Medicine.

[4]  S. Jin,et al.  Endoscopic and microscopic findings of gastrointestinal tract in Henoch–Schönlein purpura , 2019, Medicine.

[5]  M. Ohtani,et al.  The Usefulness of Video Capsule Endoscopy in Evaluating Gastrointestinal Manifestations of Immunoglobulin A Vasculitis , 2019, Internal medicine.

[6]  M. Hoang,et al.  Location of skin lesions in Henoch‐Schönlein purpura and its association with significant renal involvement , 2018, Journal of the American Academy of Dermatology.

[7]  K. Srinivasan,et al.  Gastrointestinal manifestations of Henoch-Schonlein purpura: A report of two cases. , 2015, World journal of radiology.

[8]  J. Levis,et al.  Dermatologic Diagnosis: Leukocytoclastic Vasculitis. , 2015, The Permanente journal.

[9]  J. Mao,et al.  Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management , 2015, World Journal of Pediatrics.

[10]  R. Goldman,et al.  Henoch-Schönlein purpura in children: limited benefit of corticosteroids. , 2014, Canadian family physician Medecin de famille canadien.

[11]  Yong-Beom Park,et al.  Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura , 2014, Journal of Korean medical science.

[12]  S. Kawana,et al.  Clinical significance of blood coagulation factor XIII activity in adult Henoch-Schönlein purpura. , 2013, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[13]  F. Alegre,et al.  Henoch-Schönlein purpura associated with celiac disease. , 2011, Journal of the American Academy of Dermatology.

[14]  A. Bakkaloğlu,et al.  EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.

[15]  H. McCarthy,et al.  Clinical practice: , 2010, European Journal of Pediatrics.